Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
The Lancet. Public Health
|
September 20, 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier, Yves Cottin, Pierre Coste, et al.
Archives of Cardiovascular Diseases
|
May 31, 2024
Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study
Alexandre Gautier, Nicolas Danchin, Gregory Ducrocq, et al.
The American Journal of Cardiology
|
December 25, 2012
Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)
Pascal Gueret, Jean-François Deux, Laurent Bonello, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Stefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2022
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
Anna C Mavromanoli, Stefano Barco, Walter Ageno, et al.
The Lancet. Haematology
|
August 7, 2021
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
Frederikus A Klok, Gerrit Toenges, Anna C Mavromanoli, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
Roisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
The New England Journal of Medicine
|
August 30, 2024
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Johanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
Circulation
|
June 10, 2026
Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial
Michel Zeitouni, Niki Procopi, Guillaume Cayla, et al.
Research and Practice in Thrombosis and Haemostasis
|
August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
The Lancet. Public Health
|
September 20, 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier, Yves Cottin, Pierre Coste, et al.
Archives of Cardiovascular Diseases
|
May 31, 2024
Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study
Alexandre Gautier, Nicolas Danchin, Gregory Ducrocq, et al.
The American Journal of Cardiology
|
December 25, 2012
Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)
Pascal Gueret, Jean-François Deux, Laurent Bonello, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Stefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2022
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
Anna C Mavromanoli, Stefano Barco, Walter Ageno, et al.
The Lancet. Haematology
|
August 7, 2021
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
Frederikus A Klok, Gerrit Toenges, Anna C Mavromanoli, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
Roisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
The New England Journal of Medicine
|
August 30, 2024
Beta-Blocker Interruption or Continuation after Myocardial Infarction
Johanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
Circulation
|
June 10, 2026
Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial
Michel Zeitouni, Niki Procopi, Guillaume Cayla, et al.
Research and Practice in Thrombosis and Haemostasis
|
August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Page
of 11